IQVIA HOLDINGS INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
IQVIA HOLDINGS INC. (IQV) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $64.64 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-02-17
- IQVIA HOLDINGS INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $64.64, a 7.55% increase from fiscal 2024.
- IQVIA HOLDINGS INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $60.10, a 30.28% increase from fiscal 2023.
- IQVIA HOLDINGS INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $46.13, a 48.61% increase from fiscal 2022.
- IQVIA HOLDINGS INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $31.04, a 24.07% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2025-12-31 | $64.64 10-K · filed 2026-02-17 |
| 2024-12-31 | $60.10 10-K · filed 2025-02-13 |
| 2023-12-31 | $46.13 10-K · filed 2024-02-15 |
| 2022-12-31 | $31.04 10-K · filed 2023-02-15 |
| 2021-12-31 | $40.88 10-K · filed 2022-02-16 |
| 2020-12-31 | $27.08 10-K · filed 2021-02-12 |
| 2019-12-31 | $32.56 10-K · filed 2020-02-18 |
| 2018-12-31 | $32.88 10-K · filed 2019-02-19 |
| 2017-12-31 | $34.43 10-K · filed 2018-02-16 |
| 2016-12-31 | $29.69 10-K · filed 2017-02-16 |
| 2015-12-31 | $19.41 10-K · filed 2016-02-11 |
| 2014-12-31 | $16.37 10-K · filed 2015-02-12 |
| 2013-12-31 | $13.68 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |